ReviewCardiovascular and interventional radiology2026
Interventional Radiology in the Management of Breast Cancer: Current Role and Future Directions.
Review in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer is an exceptionally common yet heterogenous malignancy, that requires cautious treatment planning through interdisciplinary communication. In this ever-evolving field, a variety of image-guided treatments are arising as promising adjuncts-or even alternatives-to conventional therapies in both early and metastatic disease. PURPOSE: In this article, we aim to briefly review the status of evidence regarding the safety and clinical outcomes of image-guided ablation in early-stage and oligometastatic breast cancer as well as the role of intra-arterial techniques in high-volume metastatic disease.
resultsCompelling prospective data support primary tumor ablation as an effective option, offering high rates of complete tumor eradication and low incidence of recurrence. The use of locoregional therapies in metastatic breast cancer, with the goal of local tumor control or even radical therapy, is emerging as a viable option in carefully selected patients; however, available data remain disparate, and further high-quality trials are warranted.
conclusionIn line with current and ongoing clinical trials, minimally invasive techniques-especially for elderly and frail individuals-represent practical solutions associated with reduced treatment-related morbidity, faster recovery times, improved patient satisfaction, and quality of life.
Indexed as
Identifiers
42637827What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.